Two Sigma Advisers’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-8,000
Closed -$545K 2366
2014
Q2
$545K Sell
8,000
-19,000
-70% -$1.27M ﹤0.01% 1613
2014
Q1
$1.75M Buy
27,000
+12,000
+80% +$756K 0.02% 839
2013
Q4
$978K Sell
15,000
-7,400
-33% -$474K 0.01% 1142
2013
Q3
$1.33M Buy
22,400
+17,400
+348% +$1.03M 0.02% 817
2013
Q2
$286K Buy
+5,000
New +$297K ﹤0.01% 1749

Other funds holding CL

Two Sigma Advisers's CL Position: Q1 2026 in Review

Two Sigma Advisers sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 604,400 shares — an estimated $47.8M sold.

Two Sigma Advisers first reported a position in CL in Q2 2013 and held it in 47 quarters. The position peaked at $284M in Q3 2018. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Two Sigma Advisers reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 604,400 Colgate-Palmolive shares in Q1 2026, an estimated $47.8M.
  • Two Sigma Advisers first reported a position in Colgate-Palmolive in Q2 2013 and held it in 47 quarters.
  • Two Sigma Advisers's Colgate-Palmolive position peaked at $284M in Q3 2018.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.